Sort
48,018 grants matching “immunotherapy”
Characterization of the Osteosarcoma Genome
$1,808,149Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Innate immune regulation of inflammation and adaptive immunity
$1,807,133Anthony L. Defranco · University Of California, San Francisco · P01 · FY2010 · AI
DNA Vaccines
$1,806,442George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
SPORE in Prostate Cancer
$1,805,886Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2024 · CA
Transplant Tolerance in Non-Human Primates
$1,805,689Christian P Larsen · Emory University · U19 · FY2007 · AI
Innate immune regulation of inflammation and adaptive immunity
$1,805,168Anthony L. Defranco · University Of California, San Francisco · P01 · FY2008 · AI
Immunotherapy to prevent drug-resistant tuberculosis
$1,804,739Rhea N Coler · Seattle Children'S Hospital · R01 · FY2020 · AI
NK cells, their receptors and cancer therapy
$1,804,682Jeffrey S Miller · University Of Minnesota · P01 · FY2023 · CA
Crystallographic studies of macromolecular structures
$1,804,628Lars Pedersen · National Institute Of Environmental Health Sciences · ZIC · FY2021 · ES
Single Cell Analysis Facility
$1,804,229Michael Kelly · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions
$1,802,154Rafael Meza · University Of Michigan At Ann Arbor · U01 · FY2020 · CA
Enhancing T Cell Therapy of Cancer
$1,801,186Baylor College Of Medicine · P01 · FY2005 · CA
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$1,800,256Jay A Berzofsky · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana
$1,799,067Roger L Shapiro · Harvard School Of Public Health · U01 · FY2023 · AI
THERAPY OF LYMPHOMA/LEUKEMIA WITH MONOCLONAL ANTIBODIES
$1,798,520Fred Hutchinson Cancer Research Center · P01 · FY2004 · CA
REGENERATIVE IMMUNOTHERAPIES
$1,798,451The Johns Hopkins University · · FY2019 · Defense Health Agency
Center for Immunotherapeutic Transport Oncophysics
$1,797,348Haifa Shen · Methodist Hospital Research Institute · U54 · FY2020 · CA
SAN DIEGO AIDS CLINICAL TRIAL UNIT
$1,794,709University Of California San Diego · U01 · FY2000 · AI
Molecular Diagnostics Core Laboratory
$1,793,683Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
SPORE in Prostate Cancer
$1,793,395William George Nelson · Johns Hopkins University · P50 · FY2015 · CA
Blood Stem Cell Transplantation as Immunotherapy
$1,792,386Samuel Strober · Stanford University · P01 · FY2013 · HL
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.
$1,791,702Michelle S Bradbury · Sloan-Kettering Inst Can Research · U54 · FY2016 · CA
IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)
$1,791,614Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2024 · AG
Elafin Therapy for Pulmonary Arterial Hypertension
$1,790,971Marlene Rabinovitch · Stanford University · P01 · FY2017 · HL
ADULT AIDS CLINICAL TRIALS UNIT
$1,790,506Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2004 · AI